Renal Cell Carcinoma: Clinical Management by Steven C. CampbellRenal Cell Carcinoma: Clinical Management by Steven C. Campbell

Renal Cell Carcinoma: Clinical Management

EditorSteven C. Campbell, Brian I. Rini

Hardcover | September 26, 2012

Pricing and Purchase Info

$282.80 online 
$323.95 list price save 12%
Earn 1414 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management. Integration of surgery and systemic therapy through cytoreductive and consolidative approaches has yielded provocative data that promises to further advance the field, and major advances in this domain are also be discussed.
Title:Renal Cell Carcinoma: Clinical ManagementFormat:HardcoverDimensions:495 pages, 10 × 7.01 × 0.01 inPublished:September 26, 2012Publisher:Humana PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1627030611

ISBN - 13:9781627030618

Look for similar items by category:

Customer Reviews of Renal Cell Carcinoma: Clinical Management

Reviews

Table of Contents

Section I: Localized Disease1.      Etiology of RCC: Incidence, Demographics, and Environmental FactorsBy Frédéric D. Birkhäuser, MD, Nils Kroeger, MD, and Allan J. Pantuck, MD MS FACS 2.      Pathology of Renal Cell CarcinomaBy Ming Zhou, MD PhD, Huiying He 3.      Familial Renal Cell CarinomaBy Simon P. Kim, MD, MPH,  Bradley C. Leibovich, MD 4.      Imaging of Renal Cell Carcinoma By Andrei S. Purysko, MD, Erick M. Remer MD, Brian R. Herts, MD 5.      Prognostic Factors for Localized Renal Cell Carcinoma By Brian R. Lane, MD, PhD. Section II: Management of  Localized RCC 6.      Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass BiopsyBy Matthew N. Simmons MD PhD,  Steven C. Campbell MD PhD 7.      Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional ConsiderationsBy Paul Russo, MD FACS 8.      Nephron-Sparing Surgery for Renal Cancer By Alon Z. Weizer MD, MS, Jeffery S. Montgomery MD, MHSA, Khaled S. Hafez, MD 9.      Thermal AblationBy Surena F. Matin MD FACS, Kamran Ahrar MD 10.  Active Surveillance of the Small Renal MassBy Marc C. Smaldone, MD, Daniel Canter,  MD, Alexander Kutikov, MD,  Robert G. Uzzo, MD FACS Section III: Locally Advanced Disease 11.  Locally Advanced Renal Cell CarcinomaBy Stephen H. Culp, MD PhD, Christopher G. Wood, MD FACS 12.  Neoadjuvant Targeted Therapy and Consolidative Surgery By Sean P. Stroup MD. Ithaar H. Derweesh, MD Section IV: Advanced Disease 13.  Biology of RCC (VEGF, mTOR, immune aspects) By Alexandra Arreola, W. Kimryn Rathmell, MD, PhD 14.  Prognostic Factors in Advanced Renal Cell Carcinoma  By Michael M. Vickers MD, Daniel Y. C. Heng MD MPH 15.  Integration of Surgery in Metastatic Renal CancerBy Tom Powles, MBBS MRCP MD,  Axel Bex, MD 16.  Immunotherapy for Renal Cell CarcinomaBy Diwakar Davar, MD,  Moon Fenton, MD, Leonard J Appleman, MD, PhD 17.  Targeted Therapy: Vascular Endothelial Growth Factor (VEGF)  By Linda Cerbone MD, Cora N. Sternberg, MD 18.  mTOR in Renal cell carcinomaBy Eric Jonasch, MD, Michel Choueiri, MD 19.  Palliative and Supportive Care for Renal Cancer By Armida Parala-Metz MD, Mellar Davis MD